Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 34:1644-1651
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koba, S.
Right arrow Articles by Benedict, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koba, S.
Right arrow Articles by Benedict, C. R.

Vascular smooth muscle proliferation

Synergistic interaction between serotonin and low density lipoproteins

Shinji Koba, MD*, Rajbabu Pakala, PhDa, Takuya Watanabe, MD*, Takashi Katagiri, MD* and Claude R. Benedict, MD, DPhil, FACCa

a Department of Internal Medicine, Division of Cardiology, University of Texas Health Science Center at Houston, Houston, Texas, USA
* Showa University School of Medicine, Tokyo, Japan



View larger version (21K):

[in a new window]
 
Figure 1 Effect of LDL and mox-LDL on 3H-thymidine incorporation into VSMC. The amount of 3H-thymidine incorporation into DNA was determined in synchronized VSMCs stimulated with indicated concentrations of LDL or mox-LDL in serum free medium for 48 h. One hundred percent equals the baseline value for 3H-thymidine incorporation into DNA (268 ± 12 cpm). Values shown are mean ± standard error. LDL = low density lipoprotein; mox-LDL = mildly oxidized low density lipoprotein; VSMC = vascular smooth muscle cell. n = 24; *p < 0.01 compared with control; **p < 0.001 compared with control.

 


View larger version (30K):

[in a new window]
 
Figure 2 Effect of 5HT on VSMC preincubated with LDL. Synchronized VSMCs were stimulated without or with different concentrations of LDL. After 24 h of incubation, indicated concentration of 5HT was added and incubated for an additional 24 h. One hundred percent equals the baseline value for 3H-thymidine incorporation into DNA (254 ± 21 cpm). Values shown are mean ± standard error. 5HT = serotonin. All other abbreviations as in Figure 1. n = 24; *p < 0.01 compared with corresponding control; **p < 0.01 compared with corresponding lipoprotein group.

 


View larger version (36K):

[in a new window]
 
Figure 3 Effect of 5HT on VSMC preincubated with mox-LDL. Synchronized VSMCs were stimulated with different concentrations of mox-LDL. After 24 h of incubation, indicated concentration of 5HT was added and incubated for an additional 24 h. One hundred percent equals the baseline value for 3H-thymidine incorporation into DNA (280 ± 19 cpm). Values shown are mean ± standard error. Abbreviations as in Figure 2. n = 24; *p < 0.01 compared with corresponding control; **p < 0.01 compared with corresponding lipoprotein group.

 


View larger version (34K):

[in a new window]
 
Figure 4 Effect of LDL or mox-LDL and 5HT on cell number. Vascular smooth muscle cells (5 x 104) were plated in 2 mL of serum free medium. After synchronization, vascular smooth muscle cells were stimulated with different concentrations of LDL or mox-LDL for 24 h, followed by incubation with 50 µmol/L of 5HT for 24 h. Then cells were trypsinized and counted as described in the Materials and Methods section. Data represent the mean ± SE from triplicate dishes from three different experiments. Baseline value is 256, 650 ± 13, 430 cells/plate. Abbreviations as in Figure 2. n = 12. *p < 0.01 compared with control; **p < 0.05 compared with corresponding control.

 


View larger version (35K):

[in a new window]
 
Figure 5 Effect of 5HT2 receptor antagonist (LY281067) on 5HT induced proliferation of LDL or mox-LDL pretreated VSMC. Synchronized VSMCs were stimulated with different concentrations of LDL or mox-LDL. 10 µg/mL of LY281067 was added 4 h before the addition of 5HT. After 24 h of incubation with LDL or mox-LDL, 50 µmol/L of 5HT was added and incubated for an additional 24 h. 3H-thymidine (1 µCi/plate) was added during the last 5 h of incubation. One hundred percent equals the baseline value for 3H-thymidine incorporation into DNA (276 ± 17 cpm). Values shown are mean ± standard error. Abbreviations as in Table 2. n = 24; *p < 0.05 compared with LDL group control; **p < 0.05 compared with corresponding LDL and 5HT group; @p < 0.01 compared with mox-LDL group control; &p < 0.001 compared with 5HT; $p < 0.001 compared with corresponding mox-LDL and 5HT group.

 


View larger version (34K):

[in a new window]
 
Figure 6 Effect of pertussis toxin (PTX) on 5HT induced proliferation of LDL or mox-LDL pretreated VSMC. Synchronized VSMCs were stimulated with different concentrations of LDL or mox-LDL in the presence or absence of 10 ng/mL of PTX. After 24 h of incubation with LDL or mox-LDL, 50 µmol/L of 5HT was added and incubated for an additional 24 h. One hundred percent equals the baseline value for 3H-thymidine incorporation into DNA (257 ± 21 cpm). Values shown are mean ± standard error. Abbreviations as in Figure 2. n = 24; *p < 0.05 compared with corresponding control; **p < 0.01 compared with LDL and 5HT group; @p < 0.01 compared with mox-LDL group control; &p < 0.001 compared with 5HT; $p < 0.001 compared with corresponding mox-LDL and 5HT group.

 


View larger version (44K):

[in a new window]
 
Figure 7 Effect of poly-I on lipoprotein and 5HT induced VSMC proliferation. Synchronized VSMCs were stimulated with different concentrations of LDL or mox-LDL in the presence or absence of 25 µg/mL of poly-I. After 24 h of incubation with LDL or mox-LDL, 50 µmol/L of 5HT was added and incubated for an additional 24 h. One hundred percent equals the baseline value for 3H-thymidine incorporation into DNA (274 ± 18 cpm). Values shown are mean ± standard error. poly-I = polyinosinic acid. All other abbreviations as in Figure 2. n = 10; *p < 0.05 compared with corresponding control; **p < 0.05 compared with corresponding lipoprotein group.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement